USE OF PEGYLATED INTERFERON ALFA-2A (PEG-IFN) IN THE SECOND LINE TREATMENT OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS (NMP): EXPERIENCE OF THE CATALAN INSTITUTE OF ONCOLOGY (ICO)

T. Quinones,M. Sagues, G. Osca,N. Estrada,C. Boque,R. Vallansot, M. Lopez-Brunso,R. Coll, E. Tuset,D. Gallardo, B. Xicoy,L. Zamora

HAEMATOLOGICA(2019)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要